Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - Axogen, Inc. | a15-14358_1ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 16, 2015
AXOGEN, INC.
(Exact name of registrant as specified in its charter)
|
Minnesota |
|
001-36046 |
|
41-1301878 |
|
(State or other jurisdiction of |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
13631 Progress Boulevard, Suite 400, Alachua, Florida |
32615 |
|
(Address of Principal Executive Offices) |
(Zip Code) |
Registrant’s telephone number, including area code
(386) 462-6800
(Former name or former address if changed since last report,)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 16, 2015, Jill Schiaparelli announced her intention to voluntarily resign from her position as Chief Marketing Officer of AxoGen, Inc. (“AxoGen”) effective July 10, 2015. AxoGen has accepted such resignation and the timing thereof.
AxoGen has begun the search for Ms. Schiaparelli’s replacement. Until her replacement is hired, Karen Zaderej, AxoGen’s President and Chief Executive Officer, will assume the responsibilities of the Chief Marketing Officer.
On June 19, 2015, AxoGen issued a press release announcing Ms. Schiaparelli’s resignation, which is included as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No. |
|
Description |
|
99.1 |
|
AxoGen, Inc. Press Release, dated June 19, 2015. |